B. Riley analyst Bryan Maher lowered the firm’s price target on Global Medical REIT to $12 from $14 and keeps a Buy rating on the shares. The analyst reduced estimates to reflect a slowdown in external growth, combined with higher interest expense.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on GMRE: